Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Total 13F shares
-
54,652,539
-
Share change
-
+1,630,665
-
Total reported value
-
$819,732,570
-
Put/Call ratio
-
83%
-
Price per share
-
$15.00
-
Number of holders
-
147
-
Value change
-
+$37,421,908
-
Number of buys
-
81
-
Number of sells
-
60
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q3 2017
As of 30 Sep 2017 SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) had 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 54,652,539 shares of stock of the company.
Largest 10 holders included BlackRock Inc., WASATCH ADVISORS INC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, FMR LLC, BAKER BROS. ADVISORS LP, D. E. Shaw & Co., Inc., Casdin Capital, LLC, and Invesco Ltd..
This table shows 147 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.